Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: A randomised, double blind, placebo-controlled trial

Veterinary Dermatology

Volumn 20, Issue 3, 2009, Pages 191-198

  Nuttall, Tim ^a   Mueller, Ralf ^b   Bensignor, Emmanuel ^c   Verde, Maite ^d   Noli, Chiara ^e   Schmidt, Vanessa ^a   Rème, Christophe ^f  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

^c CLINIQUE VÉTÉRINAIRE   (France)

^d UNIVERSITY OF ZARAGOZA   (Spain)

^e ANUBI Veterinary Hospital   (Italy)

^f Virbac SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; DRUG DERIVATIVE; HYDROCORTISONE; HYDROCORTISONE ACEPONATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HOSPITALIZATION; MALE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANIMALS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HYDROCORTISONE; MALE; PRURITUS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 65649152628     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00756.x     Document Type: Article

References (22)

1. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology 2001 81 : 147 51. (Pubitemid 32842870)
2. Olivry T, DeBoer DJ, Griffin CE et al. The ACVD task force on canine atopic dermatitis. Forewords and lexicon. Veterinary Immunology and Immunopathology 2001 81 : 143 6.
3. Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy. Veterinary Immunology and Immunopathology 2001 81 : 311 6. (Pubitemid 32842885)
4. Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy. Veterinary Immunology and Immunopathology 2001 81 : 317 22. (Pubitemid 32842886)
5. Rivierre C, Dunston SM, Olivry T. Effects of a 1 per cent hydrocortisone conditioner on the prevention of immediate and late-phase reactions in canine skin. Veterinary Record 2000 147 : 739 42. (Pubitemid 32047132)
6. DeBoer DJ, Cooley AJ. Use of induced cutaneous immediate-type hypersensitivity reactions to evaluate anti-inflammatory effects of triamcinolone topical solution in three dogs. Veterinary Dermatology 2000 11 : 25 33.
7. Kimura T, Doi K. Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids. Toxicologic Pathology 1999 27 : 528 35. (Pubitemid 29446821)
8. Thomas RC, Logas D, Radosta L, Harrison J. Effects of a 1% hydrocortisone conditioner on haematological and biochemical parameters, adrenal function testing and cutaneous reactivity to histamine in normal and pruritic dogs. Veterinary Dermatology 1999 10 : 109 16. (Pubitemid 129632836)
9. Gross TL, Walder EJ, Ihrke PJ. Subepidermal bullous dermatosis due to topical corticosteroid therapy in dogs. Veterinary Dermatology 1997 8 : 127 31. (Pubitemid 127081376)
10. Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. American Journal of Clinical Dermatology 2002 3 : 47 58. (Pubitemid 34158102)
11. Schackert C, Korting HC, Schäfer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo - Characterisation of drugs with an increased benefit-risk ratio. Biodrugs 2000 13 : 267 77. (Pubitemid 30230196)
12. Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. International Journal of Clinical Practice 2006 60 : 85 92. (Pubitemid 43732581)
13. Bieber T, Vick K, Folster-Holst R et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007 62 : 184 9. (Pubitemid 46090301)
14. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001 81 : 271 6. (Pubitemid 32842882)
15. Olivry T, Marsella R, Iwasaki T, Mueller R. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Veterinary Dermatology 2007 18 : 78 86. (Pubitemid 46393250)
16. Olivry T, Mueller RS. Evidence based veterinary dermatology: a systematic review of the pharmacotherapy of atopic dermatitis. Veterinary Dermatology 2003 14 : 121 46. (Pubitemid 37255996)
17. Marsella R, Olivry T. The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy. Veterinary Immunology and Immunopathology 2001 81 : 331 45. (Pubitemid 32842888)
18. DeBoer DJ, Griffin CE. The ACVD task force on canine atopic dermatitis (XXI): antihistamine pharmacotherapy. Veterinary Immunology and Immunopathology 2001 81 : 323 9. (Pubitemid 32842887)
19. Steffan J, Parks C, Seewald W. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association 2005 226 : 1855 63. (Pubitemid 40746061)
20. Olivry T, Guaguère E, Heripret D. Treatment of canine atopic dermatitis with misoprostol, a prostaglandin E-1 analogue: an open study. Journal of Dermatological Treatment 1997 8 : 243 7. (Pubitemid 28033798)
21. Plant JD. Repeatability and reproducibility of numerical rating scales and visual analogue scales for canine pruritus severity scoring. Veterinary Dermatology 2007 18 : 190 1. (Pubitemid 47397824)
22. Hill PB, Lau P, Rybnicek J. Development of an owner-assessed scale to measure the severity of pruritus in dogs. Veterinary Dermatology 2007 18 : 301 8. (Pubitemid 47397825)